Valery LEBOVKA, “FACTS”
Unlike Ukraine, where the vaccine against the coronavirus will be available to only 20 percent of citizens in the EU, it will receive every resident.
This is stated on the website of the European Commission.
Such a step will be possible thanks to the fact that the European Commission has completed the preliminary negotiations with pharmaceutical company Sanofi-GlaxoSmithKline to purchase the vaccine COVID-19.
It is assumed that as soon as the vaccine is found safe and effective, the EC will be a contractual framework for the procurement of 300 million doses, on behalf of all member States of the EU.
At the same time, it is noted that the Commission continues intense discussions with other vaccine manufacturers.
The European Commission also promises to help with supplies of vaccines to more vulnerable countries.
“No one is safe until all are safe,” reads the statement by the EC.
Earlier, U.S. President Donald trump said that the United States will produce 500 million doses of vaccines and the vaccine will be available in other countries.
Earlier, the “FACTS” wrote that perhaps the situation with vaccination in Ukraine will improve with the advent of the oral vaccine, which was created by a group of physicians and molecular biologists under the leadership of Daji Yana from the International hospital of Inner Mongolia (China) on a genetically modified strain of Salmonella ordinary. Thanks to her to be vaccinated will be able to attend, taking the drug in pill form on their own.